南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

利用新型抑制剂LJ-6靶向巨噬细胞中HIF-1α/IL-1β轴,可减轻细胞及体外模型中脂肪组织炎症反应

Targeting the HIF-1α/IL-1β Axis in Macrophages With the Novel Inhibitor LJ-6 Mitigates Adipose Tissue Inflammation in Cellular and Ex Vivo Models

Min Gao, Mengyuan Liu, Anran Chu, Sisi Deng, Jingsong Gao, Shasha Li, Dongsheng Jiang, Yuqing Shen, Xinyue Wang, Saifei Lei, Rui Wu, Haowen Jiang, Jia Li, Jinlong Li, Xinyi Wang, Chang Peng

Journal:Frontiers in Bioscience-Landmark

IF:4.1

DOI:10.31083/FBL53391

PMID:

Published:2026-08-21

research field:分子生物学药理学免疫学炎症研究代谢性疾病

Abstract

Background: Sustained activation of adipose tissue macrophages (ATMs) drives metabolic dysfunction in obesity, with the hypoxia-inducible factor-1α (HIF-1α)/interleukin-1β (IL-1β) axis being a core signaling pathway. However, specific strategies targeting this axis are still lacking. Here, we aimed to identify novel compounds capable of disrupting this pathway. Methods: We screened a natural product library for inhibitors of IL-1β expression in macrophages. The hit compound LJ-6 was then evaluated in lipopolysaccharide (LPS)-stimulated bone marrow-derived macrophages (BMDMs) and in a physiologically relevant model using conditioned medium from obese adipose tissue. Mechanism of action was investigated via Western blotting, molecular docking, dynamics simulations, and hypoxia-response element (HRE)-luciferase reporter assays with site-directed mutagenesis. Results: LJ-6 was identified as a potent inhibitor of IL-1β. It dose-dependently suppressedIL-1β in both LPS-induced and obese adipose tissue-conditioned medium-induced macrophage inflammation. Mechanistically, LJ-6 reduced HIF-1α protein stability. Molecular docking and mutagenesis studies supported an interaction involving the Tyr92 and His197 residues of HIF-1α, and suggested that this interaction is critical for its inhibitory function on the HIF-1α/IL-1β axis. Conclusions: This study identifies the natural compound LJ-6 as a novel direct inhibitor of HIF-1α. By binding to HIF-1α, LJ-6 effectively suppresses the HIF-1α/IL-1β axis in macrophages, thereby reducing IL-1β-driven inflammatory responses in cellular and ex vivo models of obesity-associated adipose tissue inflammation, and thus represents a promising lead compound for therapeutic development.

本文使用的Yeasen产品

购物车
客服
转染试用